Article
Effects of EPHX1 and CYP3A4*22 genetic polymorphisms on carbamazepine metabolism and drug response among Tunisian epileptic patients.
Journal of neurogenetics - 1 Mar 2016
Chbili Chahra, Fathallah Neila, Laouani Aicha, Nouira Manel, Hassine Anis, Ben Amor Sana, Ben Ammou Sofiene, Ben Salem Chaker, Saguem Saad
Abstract excerpt
The aim of this study was to evaluate the impact of polymorphisms in the EPHX1 (c.416A > G, c.337T > C) and CYP3A4*22 genes involved in carbamazepine (CBZ) metabolism and pharmacoresistance among 118 Tunisian patients with epilepsy under maintenance dose of CBZ. These genetic polymorphisms were analyzed by PCR-RFLP. Associations between plasma CBZ concentration, CBZ-E concentration, maintenance doses and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
